Communication Working Group
Dr Shams Al-Ani
Cofounder and CEO of EthixMed
Graduate Teaching Assistant at King’s College London
Dr Shams Marwan Al-Ani is a pharmacist, researcher, educator, and healthcare entrepreneur with expertise in pharmaceutical medicine, regulatory science, and health technology assessment (HTA).
She holds an MSc in Clinical Pharmacology (Pharmaceutical Medicine) from King’s College London and a Postgraduate Certificate in Medical and Healthcare Education from Anglia Ruskin University. She is currently in the final stages of her PhD at King’s College London, where her research focuses on developing and applying HTA frameworks for therapeutic medical gases.
Dr Al-Ani is the Co-Founder and Chief Executive Officer (CEO) of EthixMed, a UK-based company specialising in regulatory and research consultancy, evidence synthesis, healthcare technology assessment, and professional training.
Alongside her doctoral research, she serves as a Graduate Teaching Assistant at King’s College London, contributing to postgraduate teaching in research methods and evidence synthesis. She also supervises and assesses postgraduate research projects and is a Fellow of the Higher Education Academy (FHEA).
She is also the author of the published book chapter Interpreting Clinical Guidelines for Medicine, featured in Statistics and Data in Healthcare.
šļø Vision for MEAPP Communication Working Group
My vision as Chair of MEAPP’s Communication Working Group is is to unite professionals who share a passion for pharmaceutical medicine, bringing together expertise, ideas, and opportunities to advance the field across the Middle East and Africa.
Drawing on my academic and professional experience in the UK, I am passionate about fostering knowledge exchange, connecting regional talent with international expertise, and amplifying our collective voice. Our region has immense potential, and I believe that by working together, we can transform it into meaningful progress, drive innovation, and become active contributors to the future of pharmaceutical medicine.
I want to build a team that does more than communicate MEAPPās mission. I want us to become part of the change it represents ā turning ideas into impact, connecting people with purpose, and shaping a future where our region is not only part of global scientific progress, but actively driving it.

